Cornea / Ocular Surface

A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times

Highlights from Laboratoires Théa’s Satellite Education Program, “Ocular Surface: What’s New?” held on October 8, 2015, at the 7th EVER Congress, Nice, France.

What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?

The Light for Sight foundation provides ophthalmologists around the world with CXL training and ensures that no young patient must go without treatment

CXL is effective in slowing and halting keratoconus and corneal ectasias – but the thinnest corneas can’t receive it, so we propose a new way of bringing CXL to those that need it most

Here, we recognize a year’s worth of innovation. Apps, IOLs, imagers, lasers, devices and drugs – the latest and greatest are all here. But which one came out on top this year?

George discusses his current research focus in the field of cataract refractive surgery.

A rising star amongst the CEDARS/ASPEN set, Loh practices at the front line of refractive/cataract surgery at the South Florida Vision Associates in Fort Lauderdale

We get Bill’s perspective on what were his highlights from this year’s ESCRS congress.

Florian recalls experiences of dealing with difficult patients and talks of the advances in imaging and biometry.